A citation-based method for searching scientific literature

Gilbert J Cote, Elizabeth G Grubbs, Marie-Claude Hofmann. Recent Results Cancer Res 2015
Times Cited: 28







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
32

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
877
28

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
685
21


Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
Wendy van Veelen, Carola J R van Gasteren, Dennis S Acton, David S Franklin, Ruud Berger, Cornelis J M Lips, Jo W M Höppener. Cancer Res 2008
31
17


High-resolution analysis of alterations in medullary thyroid carcinoma genomes.
Karin Flicker, Peter Ulz, Harald Höger, Petra Zeitlhofer, Oskar A Haas, Annemarie Behmel, Wolfgang Buchinger, Christian Scheuba, Bruno Niederle, Roswitha Pfragner,[...]. Int J Cancer 2012
18
22


High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.
Margarida M Moura, Branca M Cavaco, António E Pinto, Valeriano Leite. J Clin Endocrinol Metab 2011
153
14

P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development.
Wendy van Veelen, Rob Klompmaker, Martijn Gloerich, Carola J R van Gasteren, Eric Kalkhoven, Ruud Berger, Cornelis J M Lips, Rene H Medema, Jo W M Höppener, Dennis S Acton. Int J Cancer 2009
38
14

A novel dual kinase function of the RET proto-oncogene negatively regulates activating transcription factor 4-mediated apoptosis.
Rozita Bagheri-Yarmand, Krishna M Sinha, Anupama E Gururaj, Zamal Ahmed, Yasmeen Q Rizvi, Su-Chen Huang, John E Ladbury, Oliver Bogler, Michelle D Williams, Gilbert J Cote,[...]. J Biol Chem 2015
35
14

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.
Raffaele Ciampi, Caterina Mian, Laura Fugazzola, Barbara Cosci, Cristina Romei, Susi Barollo, Valentina Cirello, Valeria Bottici, Giulia Marconcini, Pelizzo Maria Rosa,[...]. Thyroid 2013
109
14

Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon.
A Boichard, L Croux, A Al Ghuzlan, S Broutin, C Dupuy, S Leboulleux, M Schlumberger, J M Bidart, L Lacroix. J Clin Endocrinol Metab 2012
91
14

Genetics of medullary thyroid cancer: An overview.
Giacomo Accardo, Giovanni Conzo, Daniela Esposito, Claudio Gambardella, Marco Mazzella, Filomena Castaldo, Carlo Di Donna, Andrea Polistena, Nicola Avenia, Vittorio Colantuoni,[...]. Int J Surg 2017
48
14

RAS proto-oncogene in medullary thyroid carcinoma.
Margarida M Moura, Branca M Cavaco, Valeriano Leite. Endocr Relat Cancer 2015
58
10


Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.
Nishant Agrawal, Yuchen Jiao, Mark Sausen, Rebecca Leary, Chetan Bettegowda, Nicholas J Roberts, Sheetal Bhan, Allen S Ho, Zubair Khan, Justin Bishop,[...]. J Clin Endocrinol Metab 2013
147
10

Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma.
Deborah J Marsh, George Theodosopoulos, Klaus Martin-Schulte, Anne-Louise Richardson, Jeanette Philips, Hans-Dietrich Röher, Leigh Delbridge, Bruce G Robinson. J Clin Endocrinol Metab 2003
42
10


A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
175
10

Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.
Elizabeth G Grubbs, Michelle D Williams, Paul Scheet, Selina Vattathil, Nancy D Perrier, Jeffrey E Lee, Robert F Gagel, Tao Hai, Lei Feng, Maria E Cabanillas,[...]. Thyroid 2016
25
12

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine.
E Modigliani, R Cohen, J M Campos, B Conte-Devolx, B Maes, A Boneu, M Schlumberger, J C Bigorgne, P Dumontier, L Leclerc,[...]. Clin Endocrinol (Oxf) 1998
358
10

Thyroid cancer.
Maria E Cabanillas, David G McFadden, Cosimo Durante. Lancet 2016
647
10

The role of Cdk5 in neuroendocrine thyroid cancer.
Karine Pozo, Emely Castro-Rivera, Chunfeng Tan, Florian Plattner, Gert Schwach, Veronika Siegl, Douglas Meyer, Ailan Guo, Justin Gundara, Gabriel Mettlach,[...]. Cancer Cell 2013
108
10

p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
M S Park, J Rosai, H T Nguyen, P Capodieci, C Cordon-Cardo, A Koff. Proc Natl Acad Sci U S A 1999
127
10

Central role of RET in thyroid cancer.
Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
69
10

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008
327
10

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
974
10

Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
Steven I Sherman, Douglas O Clary, Rossella Elisei, Martin J Schlumberger, Ezra E W Cohen, Patrick Schöffski, Lori J Wirth, Milan Mangeshkar, Dana T Aftab, Marcia S Brose. Cancer 2016
57
10

Medullary thyroid carcinoma: a 25-year perspective.
Xavier Matias-Guiu, Ronald De Lellis. Endocr Pathol 2014
21
14

Advances and controversies in the management of medullary thyroid carcinoma.
Ana Luiza Maia, Simone Magagnin Wajner, Carla Vaz Ferreira Vargas. Curr Opin Oncol 2017
21
14

Current understanding and management of medullary thyroid cancer.
Madhuchhanda Roy, Herbert Chen, Rebecca S Sippel. Oncologist 2013
70
10

Cooperative tumorigenic effects of germline mutations in Rb and p53.
B O Williams, L Remington, D M Albert, S Mukai, R T Bronson, T Jacks. Nat Genet 1994
351
7

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
L M Mulligan, E Gardner, B A Smith, C G Mathew, B A Ponder. Genes Chromosomes Cancer 1993
122
7

Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
M Harvey, H Vogel, E Y Lee, A Bradley, L A Donehower. Cancer Res 1995
150
7

RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer.
A B Coxon, J M Ward, J Geradts, G A Otterson, M Zajac-Kaye, F J Kaye. Oncogene 1998
31
7

CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome.
T Frisk, J Zedenius, J Lundberg, G Wallin, S Kytölä, C Larsson. Int J Oncol 2001
17
11


DNA copy number changes in thyroid carcinoma.
S Hemmer, V M Wasenius, S Knuutila, K Franssila, H Joensuu. Am J Pathol 1999
87
7

Need for a revised staging consensus in medullary thyroid carcinoma.
Sarah Y Boostrom, Clive S Grant, Geoffrey B Thompson, David R Farley, Melanie L Richards, Tanya L Hoskin, Ian D Hay. Arch Surg 2009
26
7

Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.
Aniello Cerrato, Valentina De Falco, Massimo Santoro. J Mol Endocrinol 2009
54
7

Retinoblastoma expression in thyroid neoplasms.
F Anwar, M J Emond, R A Schmidt, H C Hwang, M P Bronner. Mod Pathol 2000
28
7


In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
Frauke Bentzien, Marcus Zuzow, Nathan Heald, Anna Gibson, Yongchang Shi, Leanne Goon, Peiwen Yu, Stefan Engst, Wentao Zhang, Donghui Huang,[...]. Thyroid 2013
81
7

A Drosophila model of multiple endocrine neoplasia type 2.
Renee D Read, Paul J Goodfellow, Elaine R Mardis, Nancy Novak, Jon R Armstrong, Ross L Cagan. Genetics 2005
64
7

Molecular genotyping of medullary thyroid carcinoma can predict tumor recurrence.
Hina A Sheikh, Michael Tometsko, Laura Niehouse, Dalal Aldeeb, Patricia Swalsky, Sydney Finkelstein, E Leon Barnes, Jennifer L Hunt. Am J Surg Pathol 2004
25
8

Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
F M Michiels, S Chappuis, B Caillou, A Pasini, M Talbot, R Monier, G M Lenoir, J Feunteun, M Billaud. Proc Natl Acad Sci U S A 1997
106
7


Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
597
7

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.